loading...| Preferred Name |
Ranitidine Bismuth Citrate |
|
| Synonyms |
|
|
| Definitions |
A member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C66505 |
|
| CAS_Registry |
128345-62-0 |
|
| Chemical_Formula |
C13H22N4O3S.C6H5O7.Bi |
|
| code |
C66505 |
|
| Contributing_Source |
FDA |
|
| definition |
A member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked. |
|
| FDA_UNII_Code |
7AJ51I17KG |
|
| Has_Free_Acid_Or_Base_Form | ||
| in_subset | ||
| label |
Ranitidine Bismuth Citrate |
|
| Legacy Concept Name |
Ranitidine_Bismuth_Citrate |
|
| Preferred_Name |
Ranitidine Bismuth Citrate |
|
| prefixIRI |
NCIT:C66505 |
|
| prefLabel |
Ranitidine Bismuth Citrate |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0139919 |
|
| subClassOf |